Furthermore, to confirm the above findings, BC and self-matched paracancerous tissues and the clinicopathologic characteristics (Supplementary Table 2) of 80 BC patients were collected, which showed a significantly lower SLC16A1-AS1 expression in BC tissues than in paracancerous normal tissues (Figure 1B). The gene discussed is SLC16A1; the disease is breast cancer.